Repligen Corp. (RGEN)
142.18
+2.52
(+1.80%)
USD |
NASDAQ |
Feb 06, 16:00
141.80
-0.38
(-0.27%)
After-Hours: 07:35
Repligen SG&A Expense (TTM) : 276.62M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Enovis Corp. | 1.057B |
| Abbott Laboratories | 12.33B |
| Accuray, Inc. | 88.55M |
| Alphatec Holdings, Inc. | 484.37M |
| Plus Therapeutics, Inc. | 11.09M |